日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Structural and dynamic insights into agonist recognition and function of the thromboxane A(2) receptor

血栓素A2受体激动剂识别和功能的结构和动力学研究

Krawinski, Pawel; Matzov, Donna; Ryder, Aoife; Lal, Kanhaya; Karlov, Dmitry S; Chalhoub, Georges; Mulvaney, Eamon P; Kinsella, B Therese; McCormick, Peter J; Caffrey, Martin; Tikhonova, Irina G; Shalev-Benami, Moran

Letter to the Editor: 'Rare but relevant: Genetic liver disease in the general medical setting'

致编辑的信:“罕见但重要:普通医疗环境中的遗传性肝病”

McCarron, Eamon P

Letter to the Editor: "Sarcoidosis: Key disease aspects and update on management"

致编辑的信:“结节病:疾病的关键方面和治疗进展”

McCarron, Eamon P; Wieboldt, Jason

Genetic Insights and Diagnostic Challenges in Highly Attenuated Lysosomal Storage Disorders

高度减退性溶酶体贮积症的遗传学见解和诊断挑战

Urizar, Elena; McCarron, Eamon P; Gadepalli, Chaitanya; Bentley, Andrew; Woolfson, Peter; Lin, Siying; Iosifidis, Christos; Browning, Andrew C; Bassett, John; Senarathne, Udara D; Indika, Neluwa-Liyanage R; Church, Heather J; Cooper, James A; Menendez Lorenzo, Jorge; Farrugia, Maria Elena; Jones, Simon A; Black, Graeme C; Stepien, Karolina M

Real-world clinical outcomes in adult patients with Fabry disease: A 20-year retrospective observational cohort study from a single centre

法布里病成人患者的真实世界临床结局:一项来自单一中心的20年回顾性观察队列研究

McCarron, Eamon P; Chinnadurai, Rajkumar; Meyer, Jonathan; Anderson, Thomas; Stepien, Karolina M; Sharma, Reena; Woolfson, Peter; Jovanovic, Ana

Diazoxide for Severe or Recurrent Neonatal Hypoglycemia: A Randomized Clinical Trial

二氮嗪治疗严重或复发性新生儿低血糖症:一项随机临床试验

Laing, Don; Walsh, Eamon P G; Alsweiler, Jane M; Hanning, Sara M; Meyer, Michael P; Ardern, Julena; Cutfield, Wayne S; Rogers, Jenny; Gamble, Gregory D; Chase, J Geoffrey; Harding, Jane E; McKinlay, Christopher J D

Disseminated Aspergillosis with Mediastinal Invasion Causing Fatal Stroke in an Immunocompetent Young Man

一名免疫功能正常的青年男子因播散性曲霉病伴纵隔侵犯而发生致命性中风

Yarham, Robert; Goh, Rudy; Raith, Eamon P; Sundararajan, Krishnaswamy; Kleinig, Timothy

Trained immunity is induced in humans after immunization with an adenoviral vector COVID-19 vaccine

接种腺病毒载体新冠疫苗后,人体可产生训练免疫力。

Dearbhla M Murphy ,Donal J Cox ,Sarah A Connolly ,Eamon P Breen ,Aenea Ai Brugman ,James J Phelan ,Joseph Keane ,Sharee A Basdeo

Evaluation of NTP42, a novel thromboxane receptor antagonist, in a first-in-human phase I clinical trial

在首次人体 I 期临床试验中评估新型血栓素受体拮抗剂 NTP42

Reid, Helen M; Maginn, Mark; Perkins, C Michael; Mulvaney, Eamon P; Boyce, Malcolm; Yamamoto, Takahiro; Kinsella, B Therese

The thromboxane receptor antagonist NTP42 promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload

血栓素受体拮抗剂NTP42可促进有益的适应性改变,并在右心负荷过重的实验模型中维持心脏功能。

Mulvaney, Eamon P; Renzo, Fabiana; Adão, Rui; Dupre, Emilie; Bialesova, Lucia; Salvatore, Viviana; Reid, Helen M; Conceição, Glória; Grynblat, Julien; Llucià-Valldeperas, Aida; Michel, Jean-Baptiste; Brás-Silva, Carmen; Laurent, Charles E; Howard, Luke S; Montani, David; Humbert, Marc; Vonk Noordegraaf, Anton; Perros, Frédéric; Mendes-Ferreira, Pedro; Kinsella, B Therese